Case Report
Visualizações

Arq. Bras. Oftalmol. 2024; 87 (2): 10.5935/0004-2749.2022-0091

Total: 1838

Orbital mucosa-associated lymphoid tissue (MALT) lymphoma as the initial presentation in patients with hepatitis C virus infection

Leyre Lloreda-Martin1; Ana Berrocal-Cuadrado2; Maria Angeles Torres Nieto3; Alicia Galindo-Ferreiro2

DOI: 10.5935/0004-2749.2022-0091

ABSTRACT

Hepatitis C virus infection may be implicated in 12.7% of ocular adnexal marginal zone lymphomas. We present the first case of an orbital-systemic mucosa-associated lymphoid tissue lymphoma that responded to hepatitis C virus medical treatment. A 62-year-old male with a right-sided orbital mass was diagnosed with stage IIA orbital marginal zone lymphoma in addition to hepatitis C virus infection based on clinical, imaging, laboratory, and histological examinations. The systemic and orbital responses were achieved 1 year after undergoing hepatitis C virus treatment with glecaprevir/pibrentasvir. The association between the hepatitis C virus infection and orbital-systemic mucosa-associated lymphoid tissue lymphoma is relevant. Accordingly, patients with orbital mucosa-associated lymphoid tissue lymphoma should be assessed for hepatitis C virus seroreactivity for therapeutic and prognostic purposes.

Keywords: Orbital disease; Orbital neoplasms; Lymphoma, B-cell marginal zone; Hepacivirus; Hepatitis C; Humans; Case reports


Read in English Print PDF English
Open Access
Share

How to cite this article:

Lloreda-Martin L, Berrocal-Cuadrado A, Nieto MAT, Galindo-Ferreiro A. Orbital mucosa-associated lymphoid tissue (MALT) lymphoma as the initial presentation in patients with hepatitis C virus infection. Arq. Bras. Oftalmol. 2024;87(2): e2022-0091:1-3. 10.5935/0004-2749.2022-0091
Export citation